Mike Hollan

The company is partnering with McLaren Racing and United Autosports for the event.

The investigation would determine whether excessive imports pose a threat to national security.

The basketball star has a personal history with the medication and the struggles with access to it.

This will bring Regulus’ farabursen into Novartis’ renal disease pipeline.

Capan discusses the collaboration between AWS and EVERSANA in the first part of this two-part interview.

Sheeran continues the conversation on the collaboration between AWS and EVERSANA in the second part of this interview.

The German company will expand its access into the United States through the acquisition.

The famous trees, and the festival associated with their blossoming each spring, is part of a tradition for the global pharmaceutical company.

The emerging biotech scene in Chicago has the potential to develop new treatments and technologies, but funding cuts from the federal government could have significant impact on this.

The Regeneron SVP details the company’s approach to reaching oncology patients across the planet.

Arda Ural discusses the possible impact on how companies plan for growth based on the impact of the tariffs.

The company will be adding a new manufacturing site to its NJ campus for the drug Adstiladrin.

The chaotic tariff situation is forcing pharma companies to prepare for multiple outcomes.

While supply chain interruptions are a strong possibility, the tariffs also provide the industry with a chance to improve certain conditions.

Arda Ural discusses the different ways that companies may change the ways they allocate resources in the current geopolitical climate.

Arda Ural explains how the tariffs will impact profit margins and potentially cause drug shortages.

Lynlee Brown discusses the decisions that companies must make to adjust to the tariffs while also ensuring the ongoing innovation continues.

Ted Sweetser discusses turning information into usable datasets and pulling insights from them.

Teigen’s son was diagnosed with type 1 diabetes, inspiring her to promote the importance of early testing.

Ted Sweetser discusses how more accurate datasets are solving problems related to getting communities access to better healthcare.

Ted Sweetser discusses how the technology is providing greater insight into how marketing materials are being viewed.

Ted Sweetser discusses how the technology is expanding the amount of content that can be created.

Sonam Dubey, a partner at Beghou Consulting, discusses the potential impact of a possible ban on direct-to-consumer advertising amid policy and government agency overhauls in the US.

The campaign also has a specific focus on Black Americans, who are more likely to develop the disease.

The campaign is launching alongside positive news for the company’s Phase 3 trials for a GBS treatment.

Commerce Secretary Lutnick discussed the state of the tariffs in the wake of President Trump’s comments on the pharmaceutical and electronics industries.

The Verseon CEO discusses how this advanced technology is helping to discover new drug candidates.

The company announced a new CFO along with the creation of a new role, chief medical officer.

The survey also suggests that Medicaid is broadly popular amongst all Americans, regardless of political affiliation.

Hyfe’s CEO discusses the importance of DTx and how it can change the way certain conditions are treated.